Zymedyne Therapeutics
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
CanadaWebsite
www.zymedyne.caRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Zymedyne Therapeutics
Zymedyne Therapeutics is focused on developing safe and effective non-opioid treatments for chronic pain, addressing a significant health challenge faced by society. Founded in 2020 by Drs. Gerald Zamponi and Chris Bladen from the University of Calgary, the company targets Cav3.2 T-type calcium channels to provide pain relief without the adverse effects associated with current opioid therapies. Their innovative approach aims to improve the management of chronic inflammatory and neuropathic pain for patients who are often left with unmanaged symptoms. Zymedyne's commitment to creating better pain management solutions positions them as a key player in the therapeutic landscape.Explore more
Zymedyne Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zymedyne Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Zymedyne Therapeutics is spiking on competitors!
Earning: See what the market has to say on Zymedyne Therapeutics recently announced quarterly report
Check if Zymedyne Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Zymedyne Therapeutics has new funding data
Product Launch: Get notified when Zymedyne Therapeutics launches new products
Click to see if Zymedyne Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Zymedyne Therapeutics
Zymedyne Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Zymedyne Therapeutics
Find 3 more new buyers
Compare Similar Companies to Zymedyne Therapeutics
Compare insights from companies similar to Zymedyne Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Zymedyne Therapeutics Tech Stack
A closer look at the technologies used by Zymedyne Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Zymedyne Therapeutics
Sign Up For FreeTo access detailed company insights
Zymedyne Therapeutics is focused on developing safe and effective non-opioid treatments for chronic pain, addressing a significant health challenge faced by society. Founded in 2020 by Drs. Gerald Zamponi and Chris Bladen from the University of Calgary, the company targets Cav3.2 T-type calcium channels to provide pain relief without the adverse ef... Read More
